Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1992 | 03-1992 | 12-1991 | 09-1991 | 06-1991 | |
| Operating Expenses | 2,510 | 2,390 | 0 | 2,130 | 1,850 |
| Operating Income | -2,510 | -2,390 | N/A | -2,130 | -1,850 |
| Pre-tax Income | -2,510 | -2,390 | 0 | -2,130 | -1,850 |
| Net Income Continuous | -2,510 | -2,390 | N/A | -2,130 | -1,850 |
| Net Income | $-2,510 | $-2,390 | $N/A | $-2,130 | $-1,850 |
| EBITDA(a) | $-2,510 | $-2,390 | $N/A | $-2,130 | $-1,850 |